5,116 results on '"Basiliximab"'
Search Results
2. 1 vs 7 RATG Infusions in Renal Transplantation (ONSET)
3. Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma
4. Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma
5. 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
6. Stem Cell Transplantation for Patients With Multiple Myeloma
7. A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
8. Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease.
9. Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
10. Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR (SIMPLE)
11. Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance (MSC-KTX)
12. Pediatric Induction Therapy in Kidney Transplantation (PINK)
13. Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement
14. Assessment of immunosuppression induction with basiliximab compared to antithymocyte‐globulin in adult heart transplant patients.
15. Alemtuzumab induction is associated with decreased hospitalization rates in pediatric kidney transplant: A UNOS data review for safety and outcomes with common induction regimens.
16. Induction therapy in heart transplantation: A systematic review and network meta‐analysis for developing evidence‐based recommendations.
17. Role of Induction in a Haplomatch, Related, Low-Risk, Living-Donor Kidney Transplantation with Triple Drug Immunosuppression: A Single-Center Study.
18. Efficacy and safety of single‐dose anti‐thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study.
19. Evaluation of Induction Immunosuppression and Risk of Incisional Hernia After Liver Transplantation.
20. Effect of Different Induction Immunosuppression on the Incidence of Infectious Complications after Kidney Transplantation—Single Center Study.
21. Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment.
22. A heart transplant center experience with basiliximab induction strategies: A double edged sword?
23. Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies (INSTEAD)
24. Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
25. Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center
26. Successful treatment of severe immune checkpoint inhibitor associated autoimmune hepatitis with basiliximab: a case report.
27. Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
28. DC Migration Study for Newly-Diagnosed GBM (ELEVATE)
29. Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT
30. Use of induction therapy post‐heart transplantation: Clinical practice recommendations based on systematic review and network meta‐analysis of evidence.
31. Outcomes of older Black renal transplant recipients receiving basiliximab induction and early steroid withdrawal.
32. Utilization of donor‐derived Cell‐Free DNA in pediatric kidney transplant recipients: A single center study.
33. Randomized controlled trial of sustained release tacrolimus vs twice daily tacrolimus in adult living donor liver transplantation.
34. Outcomes of kidney transplantation in patients with IgA nephropathy based on induction: A UNOS data analysis.
35. Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU study).
36. Comparative analysis of Basiliximab and Alemtuzumab induction therapies in blood type A2-to-B kidney transplantation: Impact on kidney function and de novo donor-specific HLA antibodies.
37. Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?-Preliminary assessment report.
38. Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk – a retrospective analysis of UNOS database.
39. Significant Increase in Cytomegalovirus (CMV) Infection in Solid Organ Transplants Associated With Increased Use of Thymoglobulin as Induction Therapy?
40. Advancement in preoperative desensitization therapy for ABO incompatible kidney transplantation recipients.
41. Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study.
42. Kidney transplantation in pediatric and young adults: a single - center experience.
43. Induction Therapy
44. Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation
45. Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients (TReg Kidney)
46. Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant
47. EAST HEALTH SERVICE HOSPITAL DEL SALVADOR invites tenders for Agreement for the Supply of Basiliximab 20Mg5ml Powder and Solvent for Injectable Solution in Case of Non-Dispatch of Cenabast for Hospital Del Salvador
48. FARMACEUTICA REMEDIA DISTRIBUTION & LOGISTICS S.R.L. secures contract for Various Medicinal Products - Basiliximab 20Mg Powder For Soil. Perf. Flac
49. OCCIDENTE HEALTH SERVICE SAN JUAN DE DIOS HOSPITAL invites tenders for Mdc - Supply of Basiliximab
50. Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.